Edition:
United States

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

5.25USD
23 May 2018
Change (% chg)

$-0.13 (-2.42%)
Prev Close
$5.38
Open
$5.35
Day's High
$5.50
Day's Low
$5.21
Volume
12,232
Avg. Vol
23,643
52-wk High
$5.69
52-wk Low
$2.02

Chart for

About

ADMA Biologics, Inc. is a late-stage biopharmaceutical company that develops, manufactures and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. The Company is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. Its segments... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $82.28
Shares Outstanding(Mil.): 25.79
Dividend: --
Yield (%): --

Financials

  ADMA.OQ Industry Sector
P/E (TTM): -- 84.06 32.75
EPS (TTM): -1.75 -- --
ROI: -51.15 1.57 14.38
ROE: -154.84 2.43 16.07

BRIEF-ADMA Biologics Files For Mixed Shelf Offering Of Up To $100 Mln

* ADMA BIOLOGICS FILES FOR MIXED SHELF OFFERING OF UP TO $100 MILLION - SEC FILING Source http://bit.ly/2IrSugh Further company coverage:

May 18 2018

BRIEF-Adma Biologics Granted U.S. Patent For Treating Respiratory Infections

* ADMA BIOLOGICS GRANTED U.S. PATENT FOR TREATING RESPIRATORY INFECTIONS

May 16 2018

BRIEF-ADMA Biologics Q1 Loss Per Share $0.39

* ADMA BIOLOGICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 14 2018

BRIEF-ADMA Biologics Retires About 8.6 Million Shares Previously Issued to Biotest

* ADMA BIOLOGICS INC - RETIRES APPROXIMATELY 8.6 MILLION SHARES PREVIOUSLY ISSUED TO BIOTEST PHARMACEUTICALS CORPORATION AND ITS FORMER PARENT, BIOTEST AG

May 14 2018

BRIEF-ADMA Biologics Releases Its First Commercial Batch Of Nabi-HB Manufactured Under Its Ownership

* ADMA BIOLOGICS ANNOUNCES THE RELEASE OF ITS FIRST COMMERCIAL BATCH OF NABI-HB MANUFACTURED UNDER ITS OWNERSHIP

Apr 24 2018

BRIEF-ADMA Files Biologics License Application For Its Third Plasma Collection Center

* ADMA FILES BIOLOGICS LICENSE APPLICATION FOR ITS THIRD PLASMA COLLECTION CENTER

Dec 11 2017

Competitors

  Price Chg
Baxter International Inc (BAX.N) $72.34 +0.62
Biotest AG (BIOG.DE) €25.90 0.00
Biotest AG (BIOG_p.DE) €25.45 +0.20

Earnings vs. Estimates